McKesson Pre-Tax Income 2010-2025 | MCK
McKesson annual/quarterly pre-tax income history and growth rate from 2010 to 2025. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
- McKesson pre-tax income for the quarter ending March 31, 2025 was $1.515B, a 29.49% increase year-over-year.
- McKesson pre-tax income for the twelve months ending March 31, 2025 was $4.359B, a 15.04% increase year-over-year.
- McKesson annual pre-tax income for 2025 was $4.359B, a 15.04% increase from 2024.
- McKesson annual pre-tax income for 2024 was $3.789B, a 18.16% decline from 2023.
- McKesson annual pre-tax income for 2023 was $4.63B, a 140.15% increase from 2022.
McKesson Annual Pre-Tax Income
(Millions of US $) |
| 2025 |
$4,359 |
| 2024 |
$3,789 |
| 2023 |
$4,630 |
| 2022 |
$1,928 |
| 2021 |
$-5,034 |
| 2020 |
$1,144 |
| 2019 |
$610 |
| 2018 |
$239 |
| 2017 |
$6,891 |
| 2016 |
$3,250 |
| 2015 |
$2,657 |
| 2014 |
$2,171 |
| 2013 |
$1,950 |
| 2012 |
$1,893 |
| 2011 |
$1,635 |
| 2010 |
$1,864 |
| 2009 |
$1,064 |
McKesson Quarterly Pre-Tax Income
(Millions of US $) |
| 2025-03-31 |
$1,515 |
| 2024-12-31 |
$1,226 |
| 2024-09-30 |
$534 |
| 2024-06-30 |
$1,084 |
| 2024-03-31 |
$1,170 |
| 2023-12-31 |
$612 |
| 2023-09-30 |
$916 |
| 2023-06-30 |
$1,091 |
| 2023-03-31 |
$932 |
| 2022-12-31 |
$1,448 |
| 2022-09-30 |
$1,244 |
| 2022-06-30 |
$1,006 |
| 2022-03-31 |
$647 |
| 2021-12-31 |
$277 |
| 2021-09-30 |
$442 |
| 2021-06-30 |
$562 |
| 2021-03-31 |
$1,029 |
| 2020-12-31 |
$-7,363 |
| 2020-09-30 |
$655 |
| 2020-06-30 |
$645 |
| 2020-03-31 |
$1,201 |
| 2019-12-31 |
$294 |
| 2019-09-30 |
$-970 |
| 2019-06-30 |
$619 |
| 2019-03-31 |
$-633 |
| 2018-12-31 |
$650 |
| 2018-09-30 |
$587 |
| 2018-06-30 |
$6 |
| 2018-03-31 |
$-1,094 |
| 2017-12-31 |
$697 |
| 2017-09-30 |
$178 |
| 2017-06-30 |
$458 |
| 2017-03-31 |
$4,674 |
| 2016-12-31 |
$780 |
| 2016-09-30 |
$525 |
| 2016-06-30 |
$912 |
| 2016-03-31 |
$669 |
| 2015-12-31 |
$846 |
| 2015-09-30 |
$880 |
| 2015-06-30 |
$855 |
| 2015-03-31 |
$620 |
| 2014-12-31 |
$719 |
| 2014-09-30 |
$714 |
| 2014-06-30 |
$604 |
| 2014-03-31 |
$515 |
| 2013-12-31 |
$418 |
| 2013-09-30 |
$636 |
| 2013-06-30 |
$602 |
| 2013-03-31 |
$412 |
| 2012-12-31 |
$449 |
| 2012-09-30 |
$561 |
| 2012-06-30 |
$528 |
| 2012-03-31 |
$631 |
| 2011-12-31 |
$426 |
| 2011-09-30 |
$420 |
| 2011-06-30 |
$416 |
| 2011-03-31 |
$558 |
| 2010-12-31 |
$261 |
| 2010-09-30 |
$376 |
| 2010-06-30 |
$440 |
| 2010-03-31 |
$532 |
| 2009-12-31 |
$487 |
| 2009-09-30 |
$424 |
| 2009-06-30 |
$421 |
| 2009-03-31 |
$397 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$90.804B |
$359.051B |
|
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
|
